ProfileGDS4718 / 229642_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 64% 56% 64% 62% 62% 57% 58% 57% 61% 60% 55% 66% 59% 63% 57% 56% 58% 62% 59% 67% 58% 59% 53% 60% 62% 57% 66% 67% 60% 55% 54% 62% 63% 58% 67% 61% 60% 62% 64% 65% 58% 66% 64% 60% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.394264
GSM549102patient 115, normal, homogenized [OPG study]5.8679456
GSM549104patient 119, normal, homogenized [OPG study]6.4385164
GSM549108patient 138, normal, homogenized [OPG study]6.2480262
GSM549119patient 077, normal, homogenized [OPG study]6.2871762
GSM549133patient 032, cancer, homogenized [OPG study]5.8883357
GSM549139patient 042, cancer, homogenized [OPG study]5.9610958
GSM549099patient 107, normal, homogenized [OPG study]5.924357
GSM549109patient 139, normal, homogenized [OPG study]6.2285661
GSM549110patient 046, normal, homogenized [OPG study]6.150260
GSM549114patient 063, normal, homogenized [OPG study]5.7300955
GSM549122patient 082, normal, homogenized [OPG study]6.5835866
GSM549134patient 033, cancer, homogenized [OPG study]6.0487459
GSM549136patient 036, cancer, homogenized [OPG study]6.3025363
GSM549140patient 044, cancer, homogenized [OPG study]5.8789457
GSM549111patient 047, normal, homogenized [OPG study]5.8917156
GSM549113patient 057, normal, homogenized [OPG study]5.9368658
GSM549132patient 031, cancer, homogenized [OPG study]6.2965862
GSM549137patient 038, cancer, homogenized [OPG study]6.064459
GSM549142patient 047, cancer, homogenized [OPG study]6.6766667
GSM549100patient 110, normal, homogenized [OPG study]6.0100858
GSM549107patient 135, normal, homogenized [OPG study]6.0426859
GSM549115patient 068, normal, homogenized [OPG study]5.6366453
GSM549116patient 072, normal, homogenized [OPG study]6.1126360
GSM549120patient 078, normal, homogenized [OPG study]6.239262
GSM549131patient 030, cancer, homogenized [OPG study]5.8933457
GSM549118patient 074, normal, homogenized [OPG study]6.5964466
GSM549129patient 027, cancer, homogenized [OPG study]6.6902767
GSM549123patient 088, normal, homogenized [OPG study]6.1255660
GSM549124patient 006, cancer, homogenized [OPG study]5.8203755
GSM549126patient 015, cancer, homogenized [OPG study]5.745954
GSM549128patient 025, cancer, homogenized [OPG study]6.2837162
GSM549103patient 117, normal, homogenized [OPG study]6.352263
GSM549117patient 073, normal, homogenized [OPG study]5.9150458
GSM549138patient 041, cancer, homogenized [OPG study]6.6426667
GSM549141patient 045, cancer, homogenized [OPG study]6.18761
GSM549130patient 028, cancer, homogenized [OPG study]6.1173560
GSM549101patient 111, normal, homogenized [OPG study]6.2955862
GSM549105patient 128, normal, homogenized [OPG study]6.3817464
GSM549106patient 134, normal, homogenized [OPG study]6.5369565
GSM549112patient 048, normal, homogenized [OPG study]6.0064458
GSM549125patient 011, cancer, homogenized [OPG study]6.5219566
GSM549127patient 024, cancer, homogenized [OPG study]6.4856864
GSM549135patient 035, cancer, homogenized [OPG study]6.0856360